These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34227923)

  • 21. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters.
    Nozaki Y; Izumi S
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):56-70. PubMed ID: 31901416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data.
    Nakayama K; Kamimura H; Suemizu H; Yoneda N; Nishiwaki M; Iwamoto K; Mizunaga M; Negoro T; Ito S; Yamazaki H; Nomura Y
    Drug Metab Pharmacokinet; 2020 Aug; 35(4):389-396. PubMed ID: 32690433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of chimeric mice with humanized liver for study of human-specific drug metabolism.
    Bateman TJ; Reddy VG; Kakuni M; Morikawa Y; Kumar S
    Drug Metab Dispos; 2014 Jun; 42(6):1055-65. PubMed ID: 24700822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of chimeric mice with humanized liver for predictive ADME.
    Katoh M; Yokoi T
    Drug Metab Rev; 2007; 39(1):145-57. PubMed ID: 17364883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
    Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
    Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes.
    Suemizu H; Sota S; Kuronuma M; Shimizu M; Yamazaki H
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):468-73. PubMed ID: 25158275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
    De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
    Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.
    Huang L; Berry L; Ganga S; Janosky B; Chen A; Roberts J; Colletti AE; Lin MH
    Drug Metab Dispos; 2010 Feb; 38(2):223-31. PubMed ID: 19875499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of hepatic plasma clearance in vivo from gel-entrapped rat and human hepatocytes.
    Yin J; Qiu H; Dai J; Lu Y; Zhao R; Chen L; Meng Q
    Can J Physiol Pharmacol; 2013 Feb; 91(2):178-86. PubMed ID: 23458203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of chimeric mice with humanized livers in new drug development: generation of pharmacokinetics, metabolism and toxicity data for selecting the final candidate compound.
    Kamimura H; Ito S
    Xenobiotica; 2016; 46(6):557-69. PubMed ID: 26444900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.
    Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C
    Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives.
    Zerdoug A; Le Vée M; Uehara S; Lopez B; Chesné C; Suemizu H; Fardel O
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):621-637. PubMed ID: 35793042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of human pharmacokinetics of long half-life compounds using chimeric mice with humanised liver.
    Miyamoto M; Iwasaki S; Chisaki I; Nakagawa S; Amano N; Kosugi Y; Hirabayashi H
    Xenobiotica; 2019 Dec; 49(12):1379-1387. PubMed ID: 30744481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.
    Blanchard N; Hewitt NJ; Silber P; Jones H; Coassolo P; Lavé T
    J Pharm Pharmacol; 2006 May; 58(5):633-41. PubMed ID: 16640832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models.
    Zuegge J; Schneider G; Coassolo P; Lavé T
    Clin Pharmacokinet; 2001; 40(7):553-63. PubMed ID: 11510631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of human hepatic clearance using an in vitro plated hepatocyte clearance model.
    Chao P; Barminko J; Novik E; Han Y; Maguire T; Cheng KC
    Drug Metab Lett; 2009 Dec; 3(4):296-307. PubMed ID: 20041832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2019 Mar; 47(3):320-327. PubMed ID: 30610004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.